Literature DB >> 29636215

Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial.

Joaquin A Vizcarra1, Hilary E Wilson-Perez1, Alfonso Fasano2, Alberto J Espay3.   

Abstract

Entities:  

Keywords:  Clinical trial; Motor fluctuations; Parkinson disease; SIBO; Small intestinal bacterial overgrowth

Mesh：

Substances：

Year:  2018        PMID： 29636215     DOI： 10.1016/j.parkreldis.2018.04.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  13 in total

Review 1.  Is Gut Dysbiosis an Epicenter of Parkinson's Disease?

Authors:  Charul Rajput; Alika Sarkar; Nidhi Sachan; Neeraj Rawat; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2021-01-05       Impact factor: 3.996

2.  Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.

Authors:  Xinrong Liu; Shuya Liu; Yong Tang; Zhengjia Pu; Hong Xiao; Jieying Gao; Qi Yin; Yan Jia; Qunhua Bai
Journal:  Neurochem Res       Date:  2021-03-15       Impact factor: 3.996

Review 3.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Delaram Safarpour; Kaveh Sharzehi; Ronald F Pfeiffer
Journal:  Drugs       Date:  2022-01-25       Impact factor: 9.546

Review 4.  The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.

Authors:  Ai Huey Tan; Shen Yang Lim; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2022-06-24       Impact factor: 44.711

Review 5.  Gastrointestinal dysfunction in the synucleinopathies.

Authors:  Kathryn A Chung; Ronald F Pfeiffer
Journal:  Clin Auton Res       Date:  2020-11-27       Impact factor: 4.435

Review 6.  Autonomic Dysfunction in Parkinson's Disease.

Authors:  Ronald F Pfeiffer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 7.  Association of Parkinson's Disease With Microbes and Microbiological Therapy.

Authors:  Zhao-Ji Chen; Cheng-Yu Liang; Li-Qing Yang; Si-Min Ren; Yan-Min Xia; Lei Cui; Xiao-Fang Li; Bu-Lang Gao
Journal:  Front Cell Infect Microbiol       Date:  2021-03-08       Impact factor: 5.293

Review 8.  The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance.

Authors:  Elisa Menozzi; Jane Macnaughtan; Anthony H V Schapira
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 9.  Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling.

Authors:  Sevag Hamamah; Armin Aghazarian; Anthony Nazaryan; Andras Hajnal; Mihai Covasa
Journal:  Biomedicines       Date:  2022-02-13

Review 10.  Human Gut-Microbiota Interaction in Neurodegenerative Disorders and Current Engineered Tools for Its Modeling.

Authors:  Florencia Andrea Ceppa; Luca Izzo; Lorenzo Sardelli; Ilaria Raimondi; Marta Tunesi; Diego Albani; Carmen Giordano
Journal:  Front Cell Infect Microbiol       Date:  2020-07-07       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.